Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On June 4, 2008, Grant Life Sciences, Inc. (the "Company") filed a Certificate of Designation (the "Certificate of Designation") establishing the Voting Powers, Designations, Preferences, Limitations, Restrictions, and Relative Rights of Series A Convertible Preferred Stock ("Preferred Stock") such that the number of shares constituting the Preferred Stock shall be 4,000,000. Holders of Preferred Stock shall be entitled to vote on all matters submitted to shareholders of the Company and shall be entitled to one hundred and fifty votes for each share of Preferred Stock owned at the determined record date. Subject to the terms of the Certificate of Designation, each share of Preferred Stock is convertible into ten shares of the Company's Common Stock.

A copy of the Certificate of Designation is attached as Exhibit 3.1 to this Form 8-K and is incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits

Exhibit Number Description 3.1 Certificate of Designation for Series A Convertible Preferred Stock

---